A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT01946204 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01946204
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-14
- Primary completion
- 2017-05-19
- Enrollment
- 1207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.